Mathias Lichterfeld

Discipline Director Across the Four-Year Medical Curriculum · University of Miami/Jackson Health System

Credentials: · · · · ·

History

NK Cell Targeting of HIV Reservoir Cells
National Institute of Allergy and Infectious Diseases · R37
Contact PI · $825K · Massachusetts General Hospital
2026–2031
Immune Selection of HIV-1 Reservoir Cells in Human Clinical Trials
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2.7M · Massachusetts General Hospital
2024–2029
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
National Institute of Allergy and Infectious Diseases · U01
PI · $8.2M · Harvard University d/b/a Harvard School of Public Health
2023–2028
Single-Cell Proteogenomic Profiling of HIV-1 Reservoir Cells
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $4.6M · Massachusetts General Hospital
2023–2028

Reducing the Residual Reservoir of HIV-1 Infected Cells in Patients Receiving Antiretroviral Therapy
Principal investigator · Completed · Phase 1, Phase 2
Massachusetts General Hospital
2016–2023
Early Infant HIV Treatment in Botswana
Principal investigator · Active not recruiting · Phase 2, Phase 3
Harvard School of Public Health (HSPH)
2015–2029
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Principal investigator · Completed · Phase 1
Marcus Altfeld, M.D., Ph.D.
2005–2010